Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Fisetin

Home DrugsFisetin

Experimental

Small Molecule

Fisetin

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₁₅H₁₀O₆
CAS Number: 528-48-3
UNII ID: OO2ABO9578

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

RHUS VERNICIFLUA STOKES EXTRACT HAVING INCREASED CONTENT OF ACTIVE FLAVONOID COMPOUND AND METHOD FOR PREPARING SAME
EP 2604274 B1Applicant: AZI COMPANY LTDPriority: 2010
EP
US
WO
6 publications
MEDICAL FOOD FOR COGNITIVE DECLINE
EP 2709611 A4Applicant: UNIV CALIFORNIAPriority: 2011
CN
EP
US
WO
5 publications
Method for preparing Rhus verniciflua stokes extract containing increased fisetin content, and metastasis-inhibiting anticancer agent composition containing same
US 11376295 B2Applicant: MEDIENCE CO LTDPriority: 2018
CN
US
WO
4 publications
Methods of using flavonoids to enhance memory
US 7897637 B2Applicant: SALK INST FOR BIOLOGICAL STUDIPriority: 2006
US
WO
3 publications
4′-substituted analogues of fisetin and their use in the treatment of cancer
US 12715851 B2Applicant: UNIV STELLENBOSCHPriority: 2020
US
WO
3 publications
COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION
US 20250312307 A1Applicant: NESTLE SAPriority: 2022
CN
US
2 publications
COMPOSITIONS AND METHODS USING A COMBINATION OF FISETIN AND QUERCETIN FOR CELLULAR ENERGY
US 20250319058 A1Applicant: NESTLE SAPriority: 2022
CN
US
2 publications
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND FISETIN FOR CELLULAR ENERGY
US 20250339455 A1Applicant: NESTLE SAPriority: 2022
CN
US
2 publications
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND FISETIN FOR USE IN CARTILAGE DEGENERATION
US 20250302855 A1Applicant: NESTLE SAPriority: 2022
CN
US
2 publications
COMPOSITIONS COMPRISING A COMBINATION OF FISETIN AND QUERCETIN FOR USE IN TREATING BONE DISORDERS
WO 2025108868 A1Applicant: NESTLE SAPriority: 2023
CN
WO
2 publications

Page 1 of 10